Recombined Type I Human Dermal Collagen Crystallized Powder (Structural Support Collagen Base Ingredient).
Product Overview
Recombinant Human Type I Collagen is the core structural collagen in human dermis. Prepared by genetic bioengineering technology, it features high homology with human native collagen in amino acid sequence, zero animal-derived virus risk and low immunogenicity. This sterile lyophilized powder boasts high purity, stable activity and excellent re-solubility. Focusing on skin structural support, firming repair and texture remodeling, Type I collagen has thicker and tougher fibers. It is a key raw material for improving skin texture, strengthening dermal structure and relieving sagging lines, widely applied in formula development of minimally invasive aesthetic repair, anti-aging firming and wound repair products, and compatible with various regenerative compound systems.
Core Customizable Technology
High-activity lyophilization technology: Low-temperature vacuum freeze-drying locks biological activity, completely retains collagen triple-helix structure, features fast water solubility and no caking, suitable for various preparation processes.
High-purity purification technology: Multi-stage ultrafiltration refining achieves extremely low impurity and endotoxin content with high batch consistency, meeting medical-grade raw material standards.
Controllable structural activity: Precisely retains complete functional fragments with stable cell adhesion and proliferation activity, maintaining long-term skin support.
Strong compound compatibility: Freely compatible with HA, PDLLA microspheres, Type III collagen, PDRN and other raw materials, adapting to firming anti-aging, wound repair and hydrating maintenance formulas.
Mechanism of Action
With a complete triple-helix bioactive structure, recombinant Type I collagen closely fits skin soft tissues, supplements lost structural collagen in the dermis, strengthens fiber toughness and supports collapsed skin texture. It effectively promotes fibroblast adhesion and proliferation, assists in remodeling the dermal fiber network, and improves skin sagging, dry fine lines, rough texture and skin collapse. Long-term application consolidates the underlying skin structure and enhances skin firmness and flatness, realizing long-term structural anti-aging repair.
Core Advantages
Human homologous structure with excellent biocompatibility, mild and non-irritating, free of animal-derived safety risks, suitable for sensitive skin and fragile post-procedure skin.
Outstanding structural support, specifically improves skin sagging, deepening lines and soft tissue relaxation with long-lasting firming effects.
High stability via freeze-drying technology, high tolerance for normal temperature storage, not easy to deactivate, reducing storage and loss costs of finished products.
High-purity and low-allergen formula, suitable for high-end clinical repair and long-term anti-aging finished products, complying with strict compliance standards.
Excellent compounding performance, usable alone or synergistically with various regenerative raw materials, covering full-range repair and anti-aging product lines.
Application Scenarios
OEM & Brand Manufacturing: Core raw materials for firming anti-aging lyophilized powder, structural repair essence and regenerative compound anti-aging preparation OEM.
Aesthetic Clinic Supporting Materials: Post-procedure texture repair, sagging and fine line improvement, dermal structure consolidation and long-term firming anti-aging care.
Distribution Supply: Formula sampling and R&D for brands, raw material supply for aesthetic institutions, high-end anti-aging skincare raw material cooperation at home and overseas.
Disclaimer
Our company only develops and sells medical biological raw materials, and does not manufacture or sell finished medical device products. Customers shall independently complete the R&D, processing, registration and filing of finished products after purchasing raw materials. Finished products can only be launched into the market after obtaining corresponding compliance qualifications. This document only objectively describes the physical and chemical properties and biological adaptability of raw materials and shall not constitute any efficacy commitment for finished products.
Recombined Type III Human Dermal Collagen Crystallized Powder (Softening and Repairing Collagen Base Ingredient).
Product Overview
Recombinant Human Type III Collagen, also known as "baby collagen", is the core collagen subtype of human superficial skin and newborn soft tissues, focusing on delicate repair, soothing stabilization and tissue regeneration. Prepared by biosynthetic technology, this product completely replicates the biological structure of human Type III collagen with high human homology, stable activity and excellent skin affinity. The fine soluble lyophilized powder contains no allergenic impurities, focusing on skin barrier repair, redness relief and superficial wound healing, improving rough, fragile and dull skin. It is often compounded with Type I collagen to form a golden regeneration system of "Type I for support + Type III for repair", serving as a core raw material for post-procedure repair, sensitive skin care and skin rejuvenation.
Core Customizable Technology
Bionic full-length sequence replication: Precisely replicates native human Type III collagen structure with highly compatible biological activity and higher repair efficiency.
Sterile low-temperature lyophilization: Locks high protein activity with loose and delicate powder texture, clear reconstituted solution without impurities, suitable for high-end luxury finished formulas.
Low-allergen purification process: Eliminates heterogeneous proteins and harmful impurities with extremely low endotoxin, adapting to fragile scenarios such as post-procedure and sensitive skin.
Diversified compound adaptability: Freely compatible with Type I collagen, HA gel, PDRN and peptides to balance skin repair and structural regeneration.
Mechanism of Action
Recombinant Type III collagen is highly compatible with human superficial skin tissues. It quickly penetrates the skin base, repairs damaged skin barriers, relieves redness, dry itching and sensitivity, and accelerates superficial minimally invasive wound healing. It gently activates skin cell metabolism, promotes new soft tissue growth, thickens superficial skin texture, and improves thin fragile skin, dullness and dry sensitivity. Continuous application maintains tender and hydrated skin, fades superficial fine lines, and realizes multiple effects of barrier repair, skin rejuvenation and long-term stability.
Core Advantages
Baby skin homologous collagen with mild and delicate texture and strong affinity, suitable for all skin types, especially fragile sensitive skin and post-procedure repair.
Focuses on barrier repair and soft tissue regeneration, rapidly relieves redness and sensitivity and improves thin fragile skin with obvious repair effects.
High activity retention via freeze-drying technology with stable batch quality, suitable for high-end clinical repair product development.
Animal-free, low-allergen and high-safety, avoiding viral hidden dangers and rejection risks of traditional collagen with higher compliance.
Perfectly compoundable with Type I collagen to balance structural support and superficial delicate repair, completing the full-layer skin regeneration and repair system.
Application Scenarios
OEM & Brand Manufacturing: Post-procedure repair lyophilized powder, sensitive skin soothing raw materials, skin rejuvenation essence, collagen compound repair preparation OEM.
Aesthetic Clinic Supporting Materials: Post-minimally invasive redness relief, barrier repair, daily stability care for fragile skin and superficial skin rejuvenation maintenance.
Distribution Supply: Formula R&D for beauty brands, sample procurement for aesthetic institutions, sensitive skin repair raw material cooperation at home and overseas.
Disclaimer
Our company only develops and sells medical biological raw materials, and does not manufacture or sell finished medical device products. Customers shall independently complete the R&D, processing, registration and filing of finished products after purchasing raw materials. Finished products can only be launched into the market after obtaining corresponding compliance qualifications. This document only objectively describes the physical and chemical properties and biological adaptability of raw materials and shall not constitute any efficacy commitment for finished products.